Azarga 10 mg/ml + 5 mg/ml eye drops, suspension
Authorisation EU/1/08/482/1-2 · Novartis Europharm Limited
- Licence holder
- Novartis Europharm Limited (all products →)
- Active substances
- Timolol Maleate, Brinzolamide
- Dosage form
- Eye drops, suspension
- Route of administration
- Ocular use
- ATC codes
- S01ED, S01ED51
- First authorised
- 25/11/2008
- Prescription status
- Product subject to prescription which may be renewed (B)
- Supply
- Supply through pharmacies only
- Legal basis
- New active substance (Article 8(3) of Directive No 2001/83/EC)
Timolol Maleate: supply and approvals
23 authorised products on the HPRA list contain Timolol Maleate. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.
- EU shortage (EMA)
- No entry in the EMA shortage catalogue (checked 20 Nov 2026)
- US shortage (FDA)
- No entry in the FDA drug shortage list (checked 20 Nov 2026)
- Germany (BfArM)
- 4 supply notices, e.g. Timolol Micro Labs 5 mg/ml Augentropfen, Lösung (13 Oct 2026 to 27 Nov 2026)
Registers: EU shortages · US shortages · German shortages · EMA approvals
Brinzolamide: supply and approvals
6 authorised products on the HPRA list contain Brinzolamide. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.
- EU shortage (EMA)
- No entry in the EMA shortage catalogue (checked 20 Nov 2026)
- US shortage (FDA)
- No entry in the FDA drug shortage list (checked 20 Nov 2026)
- Germany (BfArM)
- No entry in the BfArM supply notices (checked 20 Nov 2026)
Registers: EU shortages · US shortages · German shortages · EMA approvals
About this licence
Centralised EU authorisation. This product holds an EU-wide marketing authorisation granted by the European Commission after assessment by the European Medicines Agency, valid in every EU country. Its EU product number is 482. It has been authorised for 17 years (since 25 November 2008). The HPRA list does not say whether it is on sale.
Other medicines with Timolol Maleate in Ireland
11 other products on the HPRA list contain Timolol Maleate, from 8 licence holders; 4 of them are marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.
| Medicine | Licence holder | Licence | Status |
|---|---|---|---|
| COSOPT 20mg/ml + 5mg/ml eye drops, solution | Santen OY | National authorisation (PA) | Marketed |
| Latanoprost/Timolol Zentiva 50 microgram/ml + 5 mg/ml eye drops solution | Zentiva k.s. | National authorisation (PA) | Marketed |
| Tidimaz 20 mg/ml + 5 mg/ml eye drops, solution | Farmaprojects S.A.U | National authorisation (PA) | Marketed |
| Timofluid 1 mg/g eye gel in single-dose container | Laboratoires Thea | National authorisation (PA) | Marketed |
| Bitifrin 0.3 mg/ml + 5 mg/ml eye drops, solution | Farmaprojects S.A.U | National authorisation (PA) | Not marketed |
| Combigan 2 mg/ml + 5 mg/ml eye drops, solution | AbbVie Limited | National authorisation (PA) | Not marketed |
| Dorzolamide/Timolol Brown & Burk 20 mg/ml + 5 mg/ml eye drops, solution in single-dose container | Brown & Burk IR Limited | National authorisation (PA) | Not marketed |
| Duelym 0.1 mg/g + 1 mg/g eye gel in single dose container | Laboratoires Thea | National authorisation (PA) | Not marketed |
| Duotrav (Extravan) 40 micrograms/mL + 5 mg/mL eye drops, solution | Novartis Europharm Limited | Centralised EU authorisation | Not stated |
| Eyzeetan 0.3 mg/ml + 5 mg/ml eye drops, solution | Aspire Pharma (Malta) Limited | National authorisation (PA) | Not marketed |
| Loracom 50 microgram/ml + 5 mg/ml eye drops, solution | Farmaprojects S.A.U | National authorisation (PA) | Not marketed |
Other medicines with Brinzolamide in Ireland
5 other products on the HPRA list contain Brinzolamide, from 3 licence holders; 1 of them is marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.
| Medicine | Licence holder | Licence | Status |
|---|---|---|---|
| Brinzolamide 10 mg/ml eye drops, Suspension | Accord Healthcare Ireland Ltd. | National authorisation (PA) | Marketed |
| Azopt 10 mg/ml eye drops, suspension | Novartis Europharm Limited | Centralised EU authorisation | Not stated |
| Azopt 10 mg/ml eye drops, suspension | Novartis Europharm Limited | Centralised EU authorisation | Not stated |
| Brinzolamide Rowex 10 mg/ml eye drops, suspension | Rowex Limited, | National authorisation (PA) | Not marketed |
| SIMBRINZA 10 mg/mL + 2 mg/mL eye drops, suspension | Novartis Europharm Limited | Centralised EU authorisation | Not stated |
Other substances in ATC group S01ED
The ATC system groups medicines by the part of the body they act on and their chemistry. On the HPRA list, 8 other active substances share the group S01ED with this product:
Timolol (8) · Latanoprost (3) · Tafluprost (2) · Brimonidine tartrate (1) · Dorzolamide (1) · Dorzolamide hydrochloride (1) · Travopost (1) · Bimatoprost (1)
Numbers in brackets are products on the HPRA list. Sharing an ATC group does not mean two medicines can replace each other.
The licence holder
Novartis Europharm Limited holds 178 products on the HPRA list, with 65 different active substances; 0 of the products are marked as marketed.
This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.
How this page is built
The facts on this page are pulled directly from the HPRA's (Health Products Regulatory Authority) official open dataset — they are not written from memory, and nothing here is summarised or edited. Each field below names the dataset it came from, so you can check it yourself.
- HPRA Authorised Medicines List (open data) ↗ Licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status for this product
This page is built automatically: a daily sync job downloads HPRA's published XML export and copies the licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status directly into this page — no AI drafting and no per-product editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The HPRA data on this page was last retrieved on 21 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.